Therapeutic Drug Monitoring of Carbamazepine: A 20-Year Observational Study
Background: Carbamazepine (CBZ) is a first-generation anticonvulsant drug. Hence, in certain cases, therapeutic drug monitoring (TDM) supports pharmacotherapy. Methods: The presented research was based on a retrospective analysis including 710 ambulatory and hospitalized patients treated with CBZ be...
Guardado en:
Autores principales: | Grzegorz Grześk, Wioleta Stolarek, Michał Kasprzak, Elżbieta Grześk, Daniel Rogowicz, Michał Wiciński, Marek Krzyżanowski |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/087f8f7936244ffe9e332b847304279c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Relación entre niveles de carbamazepina en saliva y plasma: Estudio piloto
por: Mennickent C,Sigrid, et al.
Publicado: (2007) -
Effect of long-term administration of clonazepam, carbamazepine, and valproate on cognitive, psychological, and personality changes in adult epilepsy: a case–control study
por: Gellan K. Ahmed, et al.
Publicado: (2021) -
Protective Role of Melatonin and Taurine Against Carbamazepine-induced Toxicity in Freshly Isolated Rat Hepatocytes
por: Eghbal,Mohammad Ali, et al.
Publicado: (2013) -
DEVELOPMENT AND VALIDATION OF A METHOD USING INSTRUMENTAL PLANAR CHROMATOGRAPHY FOR QUANTITATIVE ANALYSIS OF CARBAMAZEPINE IN SALIVA
por: MENNICKENT,SIGRID, et al.
Publicado: (2003) -
Síndrome de Satoyoshi: Enfermedad multisistémica con respuesta exitosa a tratamiento esteroidal
por: Castiglioni,Claudia, et al.
Publicado: (2009)